SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007148
Filing Date
2019-08-06
Accepted
2019-08-06 07:04:47
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20190630x10q.htm 10-Q 1063437
2 EX-31.1 zyne-20190630ex311a4072e.htm EX-31.1 13578
3 EX-31.2 zyne-20190630ex312a3d8d2.htm EX-31.2 13377
4 EX-32.1 zyne-20190630ex321deec42.htm EX-32.1 6160
5 EX-32.2 zyne-20190630ex322e4e641.htm EX-32.2 6176
6 GRAPHIC zyne20190630x10q001.jpg GRAPHIC 218902
  Complete submission text file 0001558370-19-007148.txt   4728638

Data Files

Seq Description Document Type Size
7 EX-101.INS zyne-20190630.xml EX-101.INS 920938
8 EX-101.SCH zyne-20190630.xsd EX-101.SCH 33480
9 EX-101.CAL zyne-20190630_cal.xml EX-101.CAL 34369
10 EX-101.DEF zyne-20190630_def.xml EX-101.DEF 140386
11 EX-101.LAB zyne-20190630_lab.xml EX-101.LAB 289112
12 EX-101.PRE zyne-20190630_pre.xml EX-101.PRE 261652
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 191000390
SIC: 2834 Pharmaceutical Preparations